Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.

MLA

Zalacain, Vicuña, Antonio J., et al. “Efficacy and Safety of a New Medicated Nail Hydrolacquer in the Treatment of Adults with Toenail Onychomycosis: A Randomised Clinical Trial.” Mycoses, vol. 66, no. 7, July 2023, pp. 566–75. EBSCOhost, https://doi.org/10.1111/myc.13543.

APA

Zalacain, V. A. J., Nieto, C., Picas, J., Martínez, H., Bermejo, R., Corrales, A., Campos, F. F., Igea, S. A., Otero, E. F. J., & Briones, V. G. (2023). Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial. Mycoses, 66(7), 566–575. https://doi.org/10.1111/myc.13543

Chicago

Zalacain, Vicuña, Antonio J., Carlos Nieto, Jordi Picas, Helena Martínez, Rafael Bermejo, Adrián Corrales, Francisco Fernández Campos, Soledad Anguiano Igea, Espinar, Francisco Javier Otero, and Vicente García‐Patos Briones. 2023. “Efficacy and Safety of a New Medicated Nail Hydrolacquer in the Treatment of Adults with Toenail Onychomycosis: A Randomised Clinical Trial.” Mycoses 66 (7): 566–75. doi:10.1111/myc.13543.